Screening of the endothelin1 gene (EDN1) in a cohort of patients with essential left ventricular hypertrophy.

Our objective was to analyse the role of endothelin1 gene (EDN1) variation in essential left ventricular hypertrophy (LVH). We searched for EDN1 variants in 145 Spanish patients with an essential form of LVH (not secondary to hypertension, aortic stenosis, or any other disease that could explain the hypertrophy). The five EDN1 coding exons and 1.5 kilobases of the promoter region were analysed through single strand conformation analysis and direct sequencing. We found four nucleotide changes: ‐1224 C/A (promoter), ‐131 ins/del A (exon 1, 5′‐non‐translated sequence), A/G in codon 106 (exon 3, silent), and G/T in codon 198 (exon 5, lys198asn). To determine the association between these polymorphisms and cardiac hypertrophy, we compared the genotype frequencies from these 145 patients with 250 healthy controls. We found a higher frequency of patients homozygous for 198 lys (198 KK) (65% vs. 52%; p = 0.01; OR = 1.76) and for –1224 AA (73% vs. 66%; p = 0.19). Homozygotes for ‐1224 A + 198 K (AA+KK) were significantly more frequent in patients (62% vs. 45%; p = 0.0007; OR = 2.10; 95% CI = 1.35‐3.25). The expression of the –1224 C/A and exon 5 K198N variants was analysed with cells in culture. These in vitro studies showed that these variations did not differ in their expression levels. In conclusion, our work has shown that EDN1 variation, and in particular homozygosity for the ‐1224A/198K haplotype, is associated with the risk of developing cardiac hypertrophy. However, these EDN1 variants do not affect in vitro gene expression.

[1]  W. G. Hill,et al.  Estimation of linkage disequilibrium in randomly mating populations , 1974, Heredity.

[2]  K. Chien,et al.  Endothelin induction of inositol phospholipid hydrolysis, sarcomere assembly, and cardiac gene expression in ventricular myocytes. A paracrine mechanism for myocardial cell hypertrophy. , 1990, The Journal of biological chemistry.

[3]  M. Shichiri,et al.  Plasma endothelin levels in hypertension and chronic renal failure. , 1990, Hypertension.

[4]  E. Schiffrin,et al.  Plasma endothelin in human essential hypertension. , 1991, American journal of hypertension.

[5]  Y. Hirata,et al.  Endothelin-1 induces hypertrophy with enhanced expression of muscle-specific genes in cultured neonatal rat cardiomyocytes. , 1991, Circulation research.

[6]  A. Nogami,et al.  Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes. , 1993, The Journal of clinical investigation.

[7]  Y. Yazaki,et al.  Control of cardiac gene expression by mechanical stress. , 1993, Annual review of physiology.

[8]  F. Marumo,et al.  Endothelin ETA receptor antagonist blocks cardiac hypertrophy provoked by hemodynamic overload. , 1994, Circulation.

[9]  A. Marian,et al.  Recent advances in the molecular genetics of hypertrophic cardiomyopathy. , 1995, Circulation.

[10]  M. Komajda,et al.  Molecular basis of familial cardiomyopathies. , 1995, Circulation.

[11]  T. Suzuki,et al.  Endothelin-1 and its binding sites are upregulated in pressure overload cardiac hypertrophy. , 1995, The American journal of physiology.

[12]  Y. Sugishita,et al.  Inhibition of myocardial endothelin pathway improves long-term survival in heart failure , 1996, Nature.

[13]  R. Roberts,et al.  Familial hypertrophic cardiomyopathy: diagnostic and therapeutic implications of recent genetic studies. , 1996, Molecular medicine today.

[14]  R. Brugada,et al.  Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. , 1997, Journal of investigative medicine : the official publication of the American Federation for Clinical Research.

[15]  J. Sadoshima,et al.  The cellular and molecular response of cardiac myocytes to mechanical stress. , 1997, Annual review of physiology.

[16]  C. Long,et al.  Angiotensin II stimulates cardiac myocyte hypertrophy via paracrine release of TGF-beta 1 and endothelin-1 from fibroblasts. , 1998, Cardiovascular research.

[17]  Y. Kihara,et al.  Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats. , 1998, Circulation.

[18]  K. Chien,et al.  Signaling pathways for cardiac hypertrophy and failure. , 1999, The New England journal of medicine.

[19]  岩永 善高.  Cardiac endothelin-1 plays a critical role in the functional deterioration of left ventricles during the transition from compensatory hypertrophy to congestive heart failure in salt-sensitive hypertensive rats , 1999 .

[20]  D. Arveiler,et al.  The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. , 1999, Hypertension.

[21]  B. Lorell,et al.  Left ventricular hypertrophy: pathogenesis, detection, and prognosis. , 2000, Circulation.

[22]  B. McDermott,et al.  Use of A-192621 to provide evidence for involvement of endothelin ET(B)-receptors in endothelin-1-mediated cardiomyocyte hypertrophy. , 2001, European journal of pharmacology.

[23]  T. Ogihara,et al.  Endothelin-1 Gene Variant Associates With Blood Pressure in Obese Japanese Subjects: The Ohasama Study , 2001, Hypertension.

[24]  H. Park,et al.  Enhanced gene expression of renin-angiotensin system, TGF-beta1, endothelin-1 and nitric oxide synthase in right-ventricular hypertrophy. , 2001, Pharmacological research.

[25]  S. Rosenkranz,et al.  Alterations of β-adrenergic signaling and cardiac hypertrophy in transgenic mice overexpressing TGF-β1 , 2002 .

[26]  A. Vasku,et al.  The double heterozygote of two endothelin-1 gene polymorphisms (G8002A and -3A/-4A) is related to big endothelin levels in chronic heart failure. , 2002, Experimental and molecular pathology.

[27]  V. Álvarez,et al.  Hypertrophic cardiomyopathy: low frequency of mutations in the beta-myosin heavy chain (MYH7) and cardiac troponin T (TNNT2) genes among Spanish patients. , 2003, Clinical chemistry.

[28]  H. Snieder,et al.  Endothelin-1 Gene LYS198ASN Polymorphism and Blood Pressure Reactivity , 2003, Hypertension.

[29]  FernandoRodríguez-Pascual,et al.  Functional Cooperation Between Smad Proteins and Activator Protein-1 Regulates Transforming Growth Factor-β–Mediated Induction of Endothelin-1 Expression , 2003 .

[30]  A. Chakravarti,et al.  Associations Between Hypertension and Genes in the Renin-Angiotensin System , 2003, Hypertension.

[31]  K. Kohara,et al.  Association of Endothelin-1 Gene Variant With Hypertension , 2003, Hypertension.

[32]  J. Connell,et al.  The genetic determination of left ventricular mass in healthy adults. , 2003, European heart journal.

[33]  T. Niu,et al.  Role of the endothelin-1 gene locus for renal impairment in the general nondiabetic population. , 2003, Journal of the American Society of Nephrology : JASN.

[34]  D. Arnett,et al.  Genes for left ventricular hypertrophy , 2004, Current hypertension reports.

[35]  R. Shohet,et al.  Mice with cardiomyocyte-specific disruption of the endothelin-1 gene are resistant to hyperthyroid cardiac hypertrophy , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  T. Miyata,et al.  Evaluation of the Lys198Asn and -134delA genetic polymorphisms of the endothelin-1 gene. , 2004, Hypertension research : official journal of the Japanese Society of Hypertension.

[37]  H. Snieder,et al.  Endothelin-1 Gene and Progression of Blood Pressure and Left Ventricular Mass: Longitudinal Findings in Youth , 2004, Hypertension.

[38]  Miriam C J M Sturkenboom,et al.  Genetic polymorphisms and heart failure , 2004, Genetics in Medicine.

[39]  Uttam Surana,et al.  Essential tension and constructive destruction: the spindle checkpoint and its regulatory links with mitotic exit. , 2005, The Biochemical journal.

[40]  V. Álvarez,et al.  Hypertrophic cardiomyopathy linked to homozygosity for a new mutation in the myosin-binding protein C gene (A627V) suggests a dosage effect. , 2005, International journal of cardiology.

[41]  M. Redondo-Horcajo,et al.  Endothelin-1 expression is strongly repressed by AU-rich elements in the 3'-untranslated region of the gene. , 2005, The Biochemical journal.